- 1、本文档共9页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
COX-2、VEGF、MMP-2在非小细胞肺癌中表达及其意义
COX-2、VEGF、MMP-2在非小细胞肺癌中表达及其意义
作者:翁晓丹,尤庆生,施公胜,黄华
【摘要】 目的:探讨环氧化酶-2(COX-2)表达水平与非小细胞肺癌患者预后、肿瘤细胞浸润、侵袭以及新血管生成间的关系。方法:选取手术切除的肺癌标本72例,应用免疫组化方法研究肿瘤组织中COX-2、基质金属蛋白酶-2(MMP-2)、血管内皮生长因子(VEGF)的表达情况。结果:在非小细胞肺癌中COX-2的阳性表达率为54.17%,其中鳞癌的阳性表达率为43.58%,腺癌的阳性表达率为66.66%,两者间差异有统计学意义(Plt;0.05);COX-2表达还与肿瘤的组织分级、临床病理分期相关。COX-2在有淋巴结转移组中的表达明显高于无淋巴结转移组,尽管两组表达差异无统计学意义(Pgt;0.05)。COX-2的表达与VEGF、MMP-2表达成正相关。结论: COX-2是非小细胞肺癌术后患者独立的不良预后指标,COX-2可能通过促进肿瘤血管新生和浸润转移,在非小细胞肺癌的发展中扮演重要角色。
【关键词】 非小细胞肺癌;环氧化酶-2;基质金属蛋白酶-2;血管内皮生长因子;免疫组织化学
[Abstract] Objective: To study the expression of COX-2 in non-small cell lung carcinoma(NSCLC) and its relationship with prognosis and to investigate the expression relationship between COX-2,VEGF and MMP-2 to research into the role of COX-2 in NSCLC. Methods: The expression of COX-2、VEGF and MMP-2 was examined with immunohistochemical technique in 72 specimens of NSCLC resected by surgery. Results: The positive expression rate of COX-2 in NSCLC, squamous cell carcinoma and adenocarcinoma were 54.17%, 43.58%, 66.66% respectively. The expressive variation of COX-2 in SCC and AC had signigicant difference(Plt;0.05), There was a statistically significant correlationship between COX-2 expression and histological grade and TNM stage. COX-2 expression was significantly higher in sample with lymph node metastases, although there was no significant correlation between COX-2 and lymph node metastases(Pgt;0.05).In NSCLC,the positive rate of VEGF and MMP-2 were 68% and 65%. Result suggest that COX-2 expression was highly correlated to VEGF and MMP-2 expression. Survival analysis suggested COX-2 expression was an independent predictor of survival.Conclusion: COX-2 may be a useful independent poor prognostic factor of surgically resected NSCLC patients.It?s correlation to VEGF and MMP-2 indicated that COX-2 maybe play a role in NSCLC progression via angiogenesis and accelerating invasion.
[Key words] Non-small cell lung cancer; Cyclooxygenase-2; Vascular endothelial growth factor; Matrix
文档评论(0)